retatrutide fat loss clinical trial results Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide: A Triple Agonist Shaping

At 5 mg/mL, each milligram equals exactly 20 units

When you eat and drink less, you also take in fewer electrolytes , sodium, potassium, magnesium, and dehydration becomes surprisingly common on GLP-1 medications, especially if you have any vomiting or diarrhea

Separately, Pfizer entered a $2.085B deal with YaoPharma (Dec 2025) for a GLP-1 asset, and a $495M deal with Sciwind Biosciences (Feb 2026) to commercialize ecnoglutide in China

This may have implications for research cost calculations, though pricing varies significantly across vendors including Simple Peptide

In April, a paper in BMC Ophthalmology identified patterns of eye problems among people who took oral or injectable semaglutide

GLP-1 stands for glucagon-like peptide-1, a hormone your body releases naturally after meals